Staphylococcus Aureus: Clinical Trials

80 trials for Staphylococcus Aureus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

49 completed, 15 unknown, 8 terminated, 4 active not recruiting. 21 Not applicable, 8 Phase 2, 8 Phase 4, 7 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable21Completed 13, Unknown 4, Terminated 3, Recruiting 1
Phase 28Completed 5, Terminated 2, Active not recruiting 1
Phase 48Completed 6, Recruiting 1, Withdrawn 1
Phase 17Active not recruiting 3, Completed 3, Recruiting 1
Phase 34Completed 2, Terminated 2

Follow Staphylococcus Aureus: new trials by email Literature Review of Staphylococcus Aureus trials Research Report on Staphylococcus Aureus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
systematic echocardiography, no echocardiography arm - Staphylococcus Aureus, Bacteremia
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris7002025-05-142025-11-24
Decolonization Efficacy of Polyhexanide vs. Mupirocin
Polyhexanide, Mupirocin and Chlorhexidine - Staphylococcus Aureus, Colonization, Asymptomatic
Phase 4CompletedSwiss Paraplegic Research, Nottwil242025-05-012026-07-08
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
AZD7760, Placebo - Staphylococcus Aureus
Phase 1 / Phase 2Active not recruitingAstraZeneca2442024-12-302026-10-06
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Nasal Microbiota Transplant (NMT), Placebo - Staphylococcus Aureus, Microbial Colonization
Phase 1Active not recruitingJohns Hopkins University782024-09-032026-09-04
First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
HY_133, Placebo - Staphylococcus Aureus
Phase 1RecruitingUniversity Hospital Tuebingen522024-07-102024-12-06
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
nasal microbiota transplant (NMT), Placebo - Staphylococcus Aureus, Microbial Colonization
Phase 1Active not recruitingJohns Hopkins University342023-10-252025-12-11
Studying the Distribution of Accessory Gene Regulator (Agr) Quorum Sensing System and the Prevalence of Linezolid and Mupirocin Resistance in Biofilm Producer/Non Producer Staphylococcus Aureus in Sohag University Hospitals
antibiotic sensitivity test - Staphylococcus Aureus
Not applicableCompletedSohag University2652023-01-012024-03-04
Clinical Outcomes in Patients With Infection by Resistant Microorganism
Pathogen resistant phenotype - Pneumonia, Bloodstream Infection
UnknownHospital Universitario Virgen Macarena50002022-10-012023-05-30
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
Suvratoxumab, Placebo - Ventilator Associated Pneumonia, Staphylococcus Aureus
Phase 3TerminatedAridis Pharmaceuticals, Inc.242022-09-022025-03-24
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Dupilumab Prefilled Syringe - Nasal Polyps, Staphylococcus Aureus
Phase 4RecruitingUniversity of Virginia202022-09-012025-04-01
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
AP-SA02, Placebo - Bacteremia, Staphylococcus Aureus
Phase 1 / Phase 2CompletedArmata Pharmaceuticals, Inc.562022-04-262026-03-23
Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic Dermatitis
Natural Lactic Acid-enriched Cream - Staphylococcus Aureus, Atopic Dermatitis
Not applicableUnknownMicrobio Co Ltd102021-10-312021-10-25
Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
No intervention is part of the study protocol - Latent Tuberculosis, Staphylococcus Aureus
Active not recruitingRegion Skane1002021-09-302026-07-15
A Study to Investigate the Transmission and Burden of PVL-MRSA in Households in Sri Lanka
Staphylococcus Aureus
UnknownUniversity of Sheffield3002021-05-012021-05-13
S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues
Staphylococcus Aureus
UnknownRothman Institute Orthopaedics2002020-10-222020-12-14
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
Skin biopsies and blood samples - Atopic Dermatitis, Staphylococcus Aureus
Not applicableCompletedPoitiers University Hospital412020-10-152025-12-29
MSSA and MRSA Screening in Patients Undergoing Elective TJA: the Benefits of Next-generation Sequencing
next generation sequencing - Staphylococcus Aureus, Next Generation Sequencing
UnknownRothman Institute Orthopaedics1632020-08-302020-10-05
Investigation of Effectiveness of Local Antibiotic With Platelet Rich Fibrin on Third Molar Surgery Outcomes In Vivo
Diagnosis, Analgesic, traditional osteotomies - Impacted Wisdom Tooth, Pain
CompletedCeren Melahat Donmezer602020-04-202023-01-11
Targeted Gown and Glove Intervention in Nursing Homes
Targeted gown and gloves use - Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria
Not applicableTerminatedUniversity of Maryland, Baltimore42020-03-012022-11-18
Probiotics Pilot Project
Bacillus subtilis probiotic, Placebo - Staphylococcus Aureus
Not applicableUnknownRothman Institute Orthopaedics202020-02-122020-02-20

Showing 20 of 80. Sign in to see all of them.

Narrower conditions

Staphylococcal Infections (80)  ·  Surgical Wound Infection (7)  ·  Bacteremia (6)  ·  Staphylococcal Skin Infections (6)  ·  Infections (5)  ·  Sepsis (5)  ·  Cross Infection (4)  ·  Abscess (3)  ·  Furunculosis (3)  ·  Bacterial Infections (2)  ·  Communicable Diseases (2)  ·  Dermatitis, Atopic (2)  ·  Diabetic Foot (2)  ·  Endocarditis (2)  ·  Escherichia coli Infections (2)

Broader conditions

Bacterial Infections and Mycoses (80)  ·  Gram-Positive Bacterial Infections (79)  ·  Bacterial Infections (78)  ·  Infections (75)  ·  Pathological Conditions, Signs and Symptoms (32)  ·  Pathologic Processes (30)  ·  Inflammation (13)  ·  Disease Attributes (12)  ·  Skin and Connective Tissue Diseases (12)  ·  Skin Diseases (11)  ·  Systemic Inflammatory Response Syndrome (10)  ·  Skin Diseases, Infectious (7)  ·  Iatrogenic Disease (6)  ·  Postoperative Complications (6)  ·  Respiratory Tract Diseases (6)

Interventions

Mupirocin (8)  ·  chlorhexidine gluconate (5)  ·  Chlorhexidine (4)  ·  Sodium Hypochlorite (3)  ·  Blood Specimen Collection (2)  ·  Daptomycin (2)  ·  Indicator Dilution Techniques (2)  ·  Rifampin (2)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (2)  ·  suvratoxumab (2)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Adjuvants, Pharmaceutic (1)  ·  Analgesics (1)  ·  Anti-Bacterial Agents (1)  ·  Biological Oxygen Demand Analysis (1)

Sponsors

Washington University School of Medicine (4)  ·  Centre Hospitalier Universitaire de Saint Etienne (3)  ·  Henry M. Jackson Foundation for the Advancement of Military Medicine (3)  ·  Michael E. DeBakey VA Medical Center (3)  ·  Rothman Institute Orthopaedics (3)  ·  Aridis Pharmaceuticals, Inc. (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Centre Hospitalier Universitaire de Nīmes (2)  ·  Hospices Civils de Lyon (2)  ·  Johns Hopkins University (2)  ·  University of Maryland, Baltimore (2)  ·  Virginia Commonwealth University (2)  ·  AO Clinical Investigation and Publishing Documentation (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Armata Pharmaceuticals, Inc. (1)

Countries

United States (40)  ·  France (20)  ·  Spain (6)  ·  Belgium (5)  ·  Germany (5)  ·  Israel (5)  ·  Netherlands (4)  ·  Switzerland (3)  ·  Australia (2)  ·  China (2)  ·  Denmark (2)  ·  Estonia (2)  ·  Italy (2)  ·  United Kingdom (2)  ·  Argentina (1)

Top investigators

Daniel M Musher, MD (2)  ·  Stephanie A Fritz, MD, MSCI (2)  ·  Aaron Milstone (1)  ·  Aaron Milstone, MD (1)  ·  Albert Sotto, MD, PhD (1)  ·  Bernard C. Camins, MD, MSCR (1)  ·  Brian Potoski, PharmD (1)  ·  Brian S Schwartz, MD (1)  ·  Daniel M Musher, M.D. (1)  ·  David Paterson (1)  ·  Deborah Birx, MD (1)  ·  Dror Charats, Prof. (1)  ·  Eeva Ruotsalainen, MD (1)

Results publications

PMID 16420547, PMID 16965625, PMID 20686410, PMID 21028984, PMID 21248153, PMID 21444695, PMID 21828967, PMID 22198793, PMID 23099329, PMID 23549582, PMID 24633684, PMID 24836438, PMID 25203178, PMID 25421482, PMID 25695181, PMID 26209242, PMID 27387422, PMID 27720361, PMID 27780238, PMID 28815486, PMID 29530837, PMID 29954418, PMID 30629300, PMID 30907453, PMID 30975961, PMID 32219407, PMID 32521007, PMID 33077004, PMID 33215698, PMID 34901267, PMID 34945223, PMID 35962320, PMID 36242742, PMID 36715243, PMID 36965196, PMID 37726843, PMID 37815567, PMID 39212656, PMID 42314874

NIH funding

2018 (1), 2023 (1), K08AI072043 (1), R21AI179644 (1)